Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Waco
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Waco, TX

Studies commonly pay $75 to $4,500 per completed study

52 clinical trials are currently recruiting participants within 30 miles of Waco. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

52studies recruiting
5+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Waco right now

Top 25 of 52 recruiting studies, sorted by proximity — each links to its official registry page

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Atopic Dermatitis N/A Observational 1,000 participants sought
Galderma Investigational Site 8618 — Waco, Texas (2.6 mi) · Sponsor: Galderma R&D
See eligibility & contact on ClinicalTrials.gov (NCT06988605)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer Phase 1, Phase 2 Interventional 132 participants sought
Texas Oncology - Central/South Texas — Waco, Texas (2.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07421700)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Texas Oncology- Central South — Waco, Texas (2.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07144280)

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma Phase 1, Phase 2 Interventional 224 participants sought
Texas Oncology - Central South — Waco, Texas (2.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07227415)

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

Peripheral Arterial Disease Phase 3 Interventional 1,205 participants sought
NextStage Clinical Research - Waco — Waco, Texas (2.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07223593)

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 3 Interventional 2,150 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06528314)

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 1 Interventional 350 participants sought
USOR - Texas Oncology - (DFW) Waco — Waco, Texas (2.6 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See eligibility & contact on ClinicalTrials.gov (NCT06343402)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought
89bio Clinical Study Site — Waco, Texas (2.6 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06419374)

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction Associated Steatohepatitis Phase 3 Interventional 1,590 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT06632457)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigative Site 1060 — Waco, Texas (2.6 mi) · Sponsor: Anthos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05712200)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Waco, Texas (2.6 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07181109)

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Alcohol Liver Disease Phase 2 Interventional 100 participants sought
Altimmune Clinical Study Site — Waco, Texas (2.6 mi) · Sponsor: Altimmune, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07009860)

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck Phase 3 Interventional 500 participants sought
Texas Oncology-Central South — Waco, Texas (2.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07276399)

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease Phase 2 Interventional 42 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT06920043)

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Endometrial Cancer, Recurrent or Progressive Endometrial Cancer Phase 3 Interventional 660 participants sought
USOR - Texas Oncology- Horizon Circle — Waco, Texas (2.6 mi) · Sponsor: Genmab
See eligibility & contact on ClinicalTrials.gov (NCT07166094)

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Non-alcoholic Fatty Liver Disease Phase 3 Interventional 1,250 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT07221188)

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

Primary Biliary Cholangitis, PBC Phase 2 Interventional 260 participants sought
Impact Research — Waco, Texas (2.6 mi) · Sponsor: Mirum Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05050136)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06215716)
Actively enrolling

Studies you may be able to join near Waco

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for cirrhosis caused by MASH

Enrolling adults aged 18 to 80 with a physician diagnosis of liver cirrhosis caused by MASH (metabolic dysfunction-associated steatohepatitis). Not open to people with treated ascites, variceal bleeding, hepatitis B or C, or alcohol-related liver disease.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Waco

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Velocity Clinical Research

★ 4.9
6600 Fish Pond Rd #202, Waco, TX 76710
(254) 294-4780
"Everyone that works at Velocity are always very kind and considerate."
— Rose Banks, 5★

Center for Community Research and Development

★ 5.0
602 James Ave, Waco, TX 76706
(254) 710-8211

Digestive Research of Central Texas

★ 5.0
7030 New Sanger Ave Ste 204, Waco, TX 76712
(254) 218-5144

VISN 17 Center of Excellence

★ 3.7
4800 Memorial Dr Bldg 93, Waco, TX 76711
(254) 297-5155
"22 YEAR RETIRED VETERAN who has been trying to get care at the VA since Oct 2023 in 7 different categories. Patient Advocates falsely state and clo…"
— Daniel Whetzel, 1★

Baylor Scott & White McClinton Cancer Center - Waco

★ 3.1 (15 reviews)
150 Hillcrest Medical Blvd, Waco, TX 76712
(254) 202-4000
"All the staff at this cancer center are kind, considerate, and helpful with whatever you are going through. Dr. T. Is amazing and cares for his patie…"
— Dawn Hill, 5★

Clinical trials in Waco: what's recruiting

The Waco area currently has 52 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Waco, the most active research areas are:

  • Cancer & Oncology9 studies
  • Liver & Kidney9 studies
  • Diabetes & Metabolism5 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Waco, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Waco

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Waco participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How do I join a study in Waco, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Waco?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Waco?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Waco.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Waco typically complete one or two studies per year.

Paid clinical trials near Waco

Other metros within reach

Killeen, TX102 Grand Prairie, TX1,935 Arlington, TX1,856 Fort Worth, TX606 Dallas, TX1,857 Irving, TX1,967 College Station, TX46 Mesquite, TX1,759

By condition

Eligibility and exclusions, condition by condition

MASH (cirrhosis due to MASH) in Waco Bladder Issues Due To Spinal Cord Injury in Waco All conditions

More of TX

Houston3,067 Pasadena3,004 Irving1,967 Grand Prairie1,935 Dallas1,857 Arlington1,856 Garland1,818 Plano1,809 Frisco1,808 Mesquite1,759 San Antonio1,026 Austin723

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts